EFFECT of KINESIO TAPING and LASER THERAPY in PATIENT with LYMPHEDEMA on GIRTH MEASUREMENT

NCT ID: NCT06808178

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

find out the difference in the effect of kinesio taping and low level laser therapy on 66 patients with post mastectomy lymphedema as regards the following outcomes:

1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

60 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 400 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 20 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 20 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 20 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices regards the following outcomes:

1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphedema Breast Cancer Stage II

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

60 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 400 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 20 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 20 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 20 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

study group (A) include 20 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices

Group Type EXPERIMENTAL

kinesio taping

Intervention Type OTHER

* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch.
* It is made of 100% cotton to allow quickening of the drying process.
* Ability to stretch to 120-140% of its original length
* Recoil back to the anchor that is applied without stretch
* Heat-activated adhesive
* Hypoallergenic dyes that make the tape safe for most users
* Latex-free
* Drying time after being wet is about 5-10 minutes
* Can be worn for several days

Group B

study group (B) include 20 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices

Group Type EXPERIMENTAL

Low Level Laser Therapy

Intervention Type DEVICE

The device has the following treatment parametes :

* Maximum average power \> 500 milli watts
* Wave length combined (904-808) nm
* Maximum repition rate (1-2000) Hz
* Energy density : 4:6 J per cm per session

Group C

study group (C) include 20 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices

Group Type EXPERIMENTAL

Low Level Laser Therapy

Intervention Type DEVICE

The device has the following treatment parametes :

* Maximum average power \> 500 milli watts
* Wave length combined (904-808) nm
* Maximum repition rate (1-2000) Hz
* Energy density : 4:6 J per cm per session

kinesio taping

Intervention Type OTHER

* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch.
* It is made of 100% cotton to allow quickening of the drying process.
* Ability to stretch to 120-140% of its original length
* Recoil back to the anchor that is applied without stretch
* Heat-activated adhesive
* Hypoallergenic dyes that make the tape safe for most users
* Latex-free
* Drying time after being wet is about 5-10 minutes
* Can be worn for several days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low Level Laser Therapy

The device has the following treatment parametes :

* Maximum average power \> 500 milli watts
* Wave length combined (904-808) nm
* Maximum repition rate (1-2000) Hz
* Energy density : 4:6 J per cm per session

Intervention Type DEVICE

kinesio taping

* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch.
* It is made of 100% cotton to allow quickening of the drying process.
* Ability to stretch to 120-140% of its original length
* Recoil back to the anchor that is applied without stretch
* Heat-activated adhesive
* Hypoallergenic dyes that make the tape safe for most users
* Latex-free
* Drying time after being wet is about 5-10 minutes
* Can be worn for several days

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* persistence of lymphedema following mastectomy or breast conservative surgery for at least 3 months

* minimum volume difference of 200 mL or an average difference in arm circumference of 2 cm or 10% between healthy and affected limbs.
* Femal with unilateral lymphedema from 40 to 55 years old

Exclusion Criteria

* • Any disease lead to swelling

* Medication especially diuretics
* allergy
* infection
* pregnancy
* heart band kidney disease
* bilateral lymphedema
* skin disease
* chronic inflammatory disease
Minimum Eligible Age

40 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beni-Suef University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Awad Ramadan Elkholy

Lecturer of physical therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MERIT MAGDY ZAKI, physiotherapist

Role: PRINCIPAL_INVESTIGATOR

beni suif university

SHERIN HASSAN MEHANI, Professor of Physical therapy

Role: STUDY_CHAIR

beni suif university

MAHMOUD AWD ELKHOLY, Lecturer of physical therapy

Role: STUDY_DIRECTOR

beni suif university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo University Hospital

Cairo, Cairo Governorate, Egypt

Site Status

Cairo -Beni-Suif University Hospital

GIZA, Cairo Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud awd elkholy, lecturer of physical therapy

Role: CONTACT

00201125746573

SHERIN HASSAN MEHANI, Professor of Physical therapy

Role: CONTACT

00201003378217

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

mahmoud awd elkholy, lecturer

Role: primary

00201125746573

mahmoud awd El-din

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMBSUREC/02012024/Zaki

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.